| NDC Code | 62541-406-10 |
|---|
| Package Description | 2 BOTTLE, GLASS in 1 CARTON (62541-406-10) / 50 CAPSULE, DELAYED RELEASE in 1 BOTTLE, GLASS (62541-406-50) |
|---|
| Product NDC | 62541-406 |
|---|
| Product Type Name | HUMAN PRESCRIPTION DRUG |
|---|
| Proprietary Name | Pancreaze |
|---|
| Non-Proprietary Name | Pancrelipase Lipase, Pancrelipase Amylase, And Pancrelipase Protease |
|---|
| Dosage Form | CAPSULE, DELAYED RELEASE |
|---|
| Usage | ORAL |
|---|
| Start Marketing Date | 20210701 |
|---|
| Marketing Category Name | BLA |
|---|
| Application Number | BLA022523 |
|---|
| Manufacturer | VIVUS LLC |
|---|
| Substance Name | PANCRELIPASE AMYLASE; PANCRELIPASE LIPASE; PANCRELIPASE PROTEASE |
|---|
| Strength | 149900; 37000; 97300 |
|---|
| Strength Unit | [USP'U]/1; [USP'U]/1; [USP'U]/1 |
|---|